eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | intestinal disease |
| Comorbidity | C0007113|rectal cancer |
| Sentences | 46 |
| PubMedID- 22919240 | Colorectal cancer in patients with inflammatory bowel disease: can we predict risk. |
| PubMedID- 19863607 | Aim: colorectal cancer is associated with inflammatory bowel disease. |
| PubMedID- 23619008 | The risk of colorectal cancer in patients with inflammatory bowel diseases in finland: a follow-up of 20 years. |
| PubMedID- 23871359 | Oncology nurses can play an important role in providing supportive care for rectal cancer patients with bowel dysfunction. |
| PubMedID- 23664897 | Epidemiological studies demonstrate an increased risk of colorectal cancer in patients with inflammatory bowel disease (ibd). |
| PubMedID- 24652326 | The available data point toward new therapeutic perspectives for pathological features such as functional gastrointestinal disorders associated with constipation, colorectal cancer, cystic fibrosis, asthma, hypertension, gastrointestinal barrier function damage associated with enteropathy, enteric infection, malnutrition, satiety, food preferences, obesity, metabolic syndrome, and effects on behavior and brain disorders such as attention deficit, hyperactivity disorder, and schizophrenia. |
| PubMedID- 24621115 | The best surveillance practices for colorectal cancer screening in patients with inflammatory bowel disease remains unclear. |
| PubMedID- 22522090 | Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. |
| PubMedID- 21789787 | Interestingly, a recent study revealed that ntn1 expression is selectively up-regulated in colorectal cancers associated with bowel diseases. |
| PubMedID- 23407916 | Management of colorectal cancer in patients with inflammatory bowel disease. |
| PubMedID- 24280874 | Background: colitis-associated colorectal cancer affects individuals with inflammatory bowel disease (ibd) more often and earlier than cancer in the general population. |
| PubMedID- 25113042 | Chromoendoscopy for colorectal cancer surveillance in patients with inflammatory bowel disease. |
| PubMedID- 22122774 | The risk of developing colorectal cancer is increased in patients with inflammatory bowel disease (ibd). |
| PubMedID- 25557336 | Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease. |
| PubMedID- 24586180 | Chronic activation of immune responses results in health problems including gastrointestinal infections, metabolic imbalances and inflammatory bowel diseases that may lead to colorectal cancer. |
| PubMedID- 22583410 | The risk of developing colorectal cancer increases in patients with inflammatory bowel disease (ibd) and a growing body of evidence shows the critical role of interleukin (il-6) in this process. |
| PubMedID- 22228163 | Patients: colorectal cancer cases associated with inflammatory bowel disease diagnosed between 1990 and 2006 were selected in a nationwide pathology archive. |
| PubMedID- 24570133 | Purpose: to retrospectively analyze the mr imaging features of rectal cancer in patients with inflammatory bowel diseases (ibd). |
| PubMedID- 25157526 | The risk for developing dysplasia and colorectal cancer in patients with longstanding inflammatory bowel disease (ibd) involving the colon is well documented. |
| PubMedID- 24076060 | Background & aims: although restorative proctocolectomy with ileal pouch-anal anastomosis (ipaa) substantially reduces the risk of colorectal cancer in patients with inflammatory bowel disease (ibd), subsequent pouch neoplasia can develop. |
| PubMedID- 25041864 | A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease. |
| PubMedID- 22164923 | This position paper of the section of gastrointestinal oncology of the israeli gastroenterological association recommends specific guidelines for colorectal cancer surveillance in patients with inflammatory bowel disease. |
| PubMedID- 23605189 | Background: anatomical changes after intestinal resection and the effects of adjuvant treatment for colorectal cancer may lead to gastrointestinal disturbances. |
| PubMedID- 24407106 | Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases. |
| PubMedID- 20334955 | Conclusions: whereas htert immunostaining provides equivocal results, the observation that patients at high risk for colorectal cancer because of long-standing inflammatory bowel disease overexpress htert mrna in non-affected colorectal mucosa suggests its potential usefulness as a biomarker of the risk of malignant transformation. |
| PubMedID- 22398065 | Background: the increased risk of colorectal cancer (crc) in patients with inflammatory bowel disease (ibd) is well established. |
| PubMedID- 23264896 | An exaggerated inflammatory response has been reported to increase the risk of colorectal cancer in patients with inflammatory bowel disease (ibd), ulcerative colitis (uc) or crohn’s disease. |
| PubMedID- 25003290 | Conclusion: we suggest that preoperative counseling should be implemented to inform patients of the risk of bowel dysfunction, especially in patients with lower rectal cancer, although this study cannot exclude the effect of chemoradiotherapy owing to the limitation of study. |
| PubMedID- 25596747 | For instance, ulcerative colitis (uc) is an inflammatory bowel disease that is associated with colorectal cancer (crc) [2]. |
| PubMedID- 25531497 | Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk. |
| PubMedID- 24788218 | Background: active colitis impairs neoplasia detection during colonoscopic surveillance for colorectal cancer in patients with inflammatory bowel disease. |
| PubMedID- 25083052 | Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature. |
| PubMedID- 22369306 | Chronic inflammation plays a pivotal role in the development of colorectal cancer (crc) in patients with inflammatory bowel disease (ibd). |
| PubMedID- 20670073 | In the discussion, characteristics and major risk factors for colorectal cancer in patients with inflammatory bowel disease will be largely reviewed, and current studies will be analyzed in connection with the appearance of neoplasms in patients being treated with biologics. |
| PubMedID- 23709348 | The risk of developing colorectal cancer (crc) increases in patients with inflammatory bowel disease. |
| PubMedID- 25849652 | [22] mir-21 was increased in inflammatory bowel disease (ibd) with or without colorectal cancer. |
| PubMedID- 23169309 | Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development. |
| PubMedID- 25840920 | Molecular alterations of colorectal cancer with inflammatory bowel disease. |
| PubMedID- 24463282 | The risk of developing colorectal cancer is increased in patients with inflammatory bowel disease. |
| PubMedID- 21085072 | Surveillance for colorectal cancer in patients with inflammatory bowel disease. |
| PubMedID- 23086115 | Background: differentiating surveillance from non-surveillance colonoscopy for colorectal cancer in patients with inflammatory bowel disease (ibd) using electronic medical records (emr) is important for practice improvement and research purposes, but diagnosis code algorithms are lacking. |
| PubMedID- 21386829 | A classic paradigm is the enhanced risk of colorectal cancer (crc) in patients with inflammatory bowel disease (ibd). |
| PubMedID- 25337558 | Various chemopreventive agents have been clearly shown to reduce the risk of colorectal adenoma and cancer in the general population and the problems associated with colonoscopic surveillance have led to increasing interest in utilising chemopreventive strategies to reduce the risk of colorectal cancer in patients with inflammatory bowel disease as well.30 because colitis-associated cancers arose in the setting of chronic inflammation, during which “inflammation-dysplasia-carcinoma sequence” prevails and anti-inflammatory agents can prevent carcinogenesis, we have published data regarding chemoprevention of colitic cancer using infliximab31 and 8-ohdg.32 apart from colitic cancer, colorectal carcinogenesis is also based on a multi-step process characterized by molecular and cellular alterations that result in an identifiable precursor lesion, ie, the adenomatous polyp.33 the transition from normal mucosa to adenoma and its subsequent progression to carcinoma are protracted events that offer opportunities for preventive interventions. |
| PubMedID- 25531498 | This review summarizes the advances and current standards of colorectal cancer prevention in patients with inflammatory bowel disease, fap and lynch syndrome. |
| PubMedID- 25230162 | Colorectal cancer surveillance in patients with inflammatory bowel disease and primary sclerosing cholangitis: an economic evaluation. |
| PubMedID- 22523611 | Colorectal cancer surveillance in patients with inflammatory bowel disease: what is new. |
Page: 1